Stoneware Innovation: 158 million restricted shares will be listed for trading on November 17th.

Stone Pharmaceuticals announced that a portion of the restricted shares related to the issuance of shares for the acquisition of assets will be listed for trading. The number of restricted shares to be released this time is 158 million shares, accounting for 11.2147% of the total share capital of the company. The date of listing for trading is November 17, 2025, and the only shareholder applying for the release of restricted shares is Enbipu Pharmaceuticals. Stone Pharmaceuticals has completed the performance commitment for the years 2022-2024 without impairing equity, and no compensation is required. The independent financial advisor has verified that the release of restricted shares and listing for trading in this case comply with regulations, and the related shareholders have not violated their commitments.